Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6274 USD | -0.80% | -2.34% | -16.04% |
May. 07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.04% | 13.34M | |
+68.69% | 62.86B | |
-0.80% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.11% | 26.46B | |
-22.55% | 18.9B | |
+4.74% | 12.67B | |
+24.08% | 12.27B | |
+27.92% | 12.07B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Transcript : Onconova Therapeutics, Inc., Q3 2023 Earnings Call, Nov 14, 2023